Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Research Articles

Vol. 13 No. 4 (2026)

Antiparasitic activity of Loranthus europaeus Jacq. against Acanthamoeba sp.: An in vitro study

DOI
https://doi.org/10.14719/pst.16233
Submitted
20 June 2026
Published
29-09-2026 — Updated on 01-10-2026
Versions

Abstract

Acanthamoeba keratitis (AK), caused by species of the genus Acanthamoeba, has become more frequently reported in recent years, particularly among contact lens users and immunocompromised individuals. Although the disease is rare, it can cause blindness; treatment resistance and limited access to care are growing concerns. This study evaluated the antiparasitic activity of Loranthus europaeus Jacq. hexane extract against trophozoite and cyst stages of Acanthamoeba sp. and identify its chemical constituents by gas chromatography-mass spectrometry (GC-MS). Serial extract concentrations (1.25, 2.5, 5 and 10 mg/mL) were applied to trophozoite and cyst suspensions for 2, 4 and 6 min and viability was assessed microscopically using trypan blue exclusion. The extract demonstrated a clear concentration and time-dependent reduction in viability (two-way analysis of variance (ANOVA), p < 0.001), reaching 0.33 ± 0.58 % at the highest concentration and longest exposure for both stages. IC₅₀ values ranged from 0.93–3.03 mg/mL across exposure times. The negative control showed no effect, whereas polyhexamethylene biguanide (PHMB, 0.02 %) reduced viability to a residual 30.67 ± 1.15 % at 6 min for both stages. The GC-MS analysis revealed a triterpenoid-rich profile 47.72 % dominated by Lup-20(29)-en-3beta-ol, acetate 42.06 % followed by sesquiterpene longipinane, germacrene D and caryophyllene. The GC-MS identifications further confirmed by retention index matching to published values. These findings point to preliminary, in vitro antiparasitic activity of L. europaeus extract against Acanthamoeba sp. an effect that may be linked to the terpenoid compounds detected in the extract. Before any translational application can be considered, further work is needed to purify the active compounds, clarify how they act and confirm the extract's safety for corneal cells.

References

  1. 1. Baranowska M, Dylewski Ł, Galko J, Korzeniewicz R, Kowalkowski W, Łukowski A, et al. Loranthus europaeus Jacq. In European broadleaf forests: ecology, impact and management implications. For Ecol Manage. 2026;612:123756. https://doi.org/10.1016/j.foreco.2026.123756
  2. 2. Gebauer R. International Biological Flora: Loranthus europaeus No. 8. J Ecol. 2026. https://doi.org/10.1111/1365-2745.70311
  3. 3. Shavvon RS, Mehrvarz SS, Golmohammadi N. Evidence from micromorphology and gross morphology of the genus Loranthus (Loranthaceae) in Iran. Turk J Bot. 2012;36(6):655–66. https://doi.org/10.3906/bot-1105-22
  4. 4. Sharquie K, Noaimi A, Saleh B. Loranthus europaeus as an alternative medicine in treatment of acute cutaneous leishmaniasis: review article. J Cosmet Dermatol Sci Appl. 2016;6:24–33. https://doi.org/10.4236/jcdsa.2016.61004
  5. 5. Lakatos F, Mirtchev S. Handbook of the major forest pests in South East Europe. 2014.
  6. 6. Abdel Rasool AM, Qader KO, Mustafa NW. Anticancer promise of Loranthus europaens extract impact on the AMJ13 breast cancer cell line. Health Biotechnol Biopharma. 2025;9(2):117–34.
  7. 7. Benabderrahim MA, Elfalleh W, Sarikurkcu C, Sarikurkcu RB. Biological activities and phytochemical composition of organs from Loranthus europaeus. Ind Crops Prod. 2019;141:111772. https://doi.org/10.1016/j.indcrop.2019.111772
  8. 8. Çömlekçioğlu N, Korkmaz N, Yüzbaşıoğlu MA, Uysal İ, Sevindik M. Mistletoe (Loranthus europaeus Jacq.): antioxidant, antimicrobial and anticholinesterase activities. Prospect Pharm Sci. 2024;22(3):164–9. https://doi.org/10.56782/pps.213
  9. 9. Bao M, Bao H, Wang S, Zhou H. The pathogenesis, risk factors, diagnosis and treatment of Acanthamoeba keratitis. Front Med. 2025;12:1559224. https://doi.org/10.3389/fmed.2025.1559224
  10. 10. Bogitsh BJ, Carter CE, Oeltmann TN. Visceral protista I: rhizopods (amoebae) and ciliophorans. In: Human Parasitology. 5th ed. London, UK: Elsevier Academic Press; 2019. https://doi.org/10.1016/B978-0-12-813712-3.00004-7
  11. 11. Garg D, Daigavane S. A comprehensive review on Acanthamoeba keratitis: an overview of epidemiology, risk factors and therapeutic strategies. Cureus. 2024;16(8). https://doi.org/10.7759/cureus.67803
  12. 12. Patel NV, Mathur U, Sawant S, Acharya M, Gandhi A, Sawant Sr S. Three consecutive cases of ocular polyhexamethylene biguanide (PHMB) toxicity due to compounding error. Cureus. 2023;15(5). https://doi.org/10.7759/cureus.38540
  13. 13. Mafra CSP, Carrijo-Carvalho LC, Chudzinski-Tavassi AM, de Carvalho Taguchi FM, Foronda AS, de Souza Carvalho FR, et al. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity. Invest Ophthalmol Vis Sci. 2013;54(9):6363–72. https://doi.org/10.1167/iovs.13-11990
  14. 14. Abu Dail Y, Flockerzi E, Munteanu C, Szentmáry N, Seitz B, Daas L. Rethinking keratoplasty for patients with Acanthamoeba keratitis: early “low load keratoplasty” in contrast to late optical and therapeutic keratoplasty. Microorganisms. 2024;12(9):1801. https://doi.org/10.3390/microorganisms12091801
  15. 15. Scruggs BA, Quist TS, Zimmerman MB, Salinas JL, Greiner MA. Risk factors, management and outcomes of Acanthamoeba keratitis: a retrospective analysis of 110 cases. Am J Ophthalmol Case Rep. 2022;25:101372. https://doi.org/10.1016/j.ajoc.2022.101372
  16. 16. Gutierrez-Grijalva EP, Contreras-Angulo LA, Criollo-Mendoza MS, Heredia JB, Lopez-Cervantes J, Sanchez-Machado DI, et al. Phytochemicals as promising agents against pathogenic free-living amoebas. Phytochem Rev. 2026;25:1109–25. https://doi.org/10.1007/s11101-025-10158-x
  17. 17. Anwar A, Ting ELS, Anwar A, Ain NU, Faizi S, Shah MR, et al. Antiamoebic activity of plant-based natural products and their conjugated silver nanoparticles against Acanthamoeba castellanii (ATCC 50492). AMB Express. 2020;10:24. https://doi.org/10.1186/s13568-020-0960-9
  18. 18. Lê HG, Hwang BS, Choi JS, Jeong YT, Kang JM, Võ TC, et al. Iris setosa Pall. ex Link extract reveals amoebicidal activity against Acanthamoeba castellanii and Acanthamoeba polyphaga with low toxicity to human corneal cells. Microorganisms. 2024;12(8):1658. https://doi.org/10.3390/microorganisms12081658
  19. 19. Lê HG, Choi JS, Hwang BS, Jeong YT, Kang JM, Võ TC, et al. Phragmites australis (Cav.) Trin. ex Steud. extract induces apoptosis-like programmed cell death in Acanthamoeba castellanii trophozoites. Plants. 2022;11(24):3459. https://doi.org/10.3390/plants11243459
  20. 20. Dodangeh S, Niyyati M, Kamalinejad M, Lorenzo-Morales J, Moshfe A, Haghighi A, et al. In-vitro activity of Trigonella foenum-graecum seeds against a clinical strain of Acanthamoeba genotype T4. Iran J Pharm Res. 2018;17(2):661–7.
  21. 21. Muino L, Rodrigo D, Villegas R, Romero P, Peredo DE, Vargas RA, et al. Effectiveness of sampling methods employed for Acanthamoeba keratitis diagnosis by culture. Int Ophthalmol. 2019;39:1451–58. https://doi.org/10.1007/s10792-018-0958-3
  22. 22. Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors and antimicrobial resistance. Eye. 2021;35:1084–101. https://doi.org/10.1038/s41433-020-01339-3
  23. 23. El-Sayed NM, Hikal WM. Several staining techniques to enhance the visibility of Acanthamoeba cysts. Parasitol Res. 2015;114(3):823–30. https://doi.org/10.1007/s00436-014-4190-4
  24. 24. Pussard M, Pons R. Morphologie de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida). Protistologica. 1977;3:557–98.
  25. 25. Page FC. A new key to freshwater and soil amoebae: with notes on cultivation and ecology. Freshwater Biological Association (FBA) Scientific Publication No. 51. Ambleside, UK: Freshwater Biological Association; 1988.
  26. 26. Matsubara K, Hirose R, Hasegawa N, Minamiyama T, Kano T, Sai A, et al. A rapid and accurate protocol for quantifying living Acanthamoeba castellanii cysts. Microbiol Spectr. 2025;13(10):e01170–25. https://doi.org/10.1128/spectrum.01170-25
  27. 27. Bernardes G, Alves D, da Silva DC, Alves LM, Castro AM, Vinaud MC. Viability test exclusively is not adequate to evaluate the T4 Acanthamoeba keratitis’ treatment. J Microbiol Exp. 2020;8(1):1–5. https://doi.org/10.15406/jmen.2020.08.00278
  28. 28. Baig AM, Iqbal J, Khan NA. In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype. Antimicrob Agents Chemother. 2013;57(8):3561–7. https://doi.org/10.1128/AAC.00299-13
  29. 29. Larkin DFP, Kilvington S, Dart JKG. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology. 1992;99(2):185–91. https://doi.org/10.1016/S0161-6420(92)31994-3
  30. 30. van den Dool H, Kratz PD. A generalization of the retention index system including linear temperature programmed gas-liquid partition chromatography. J Chromatogr A. 1963;11:463–71. https://doi.org/10.1016/S0021-9673(01)80947-X
  31. 31. Pardo-Rodriguez D, Cifuentes-López A, Bravo-Espejo J, Romero I, Robles J, Cuervo C, et al. Lupeol acetate and α-amyrin terpenes activity against Trypanosoma cruzi: insights into toxicity and potential mechanisms of action. Trop Med Infect Dis. 2023;8(5):263. https://doi.org/10.3390/tropicalmed8050263
  32. 32. Greggs JR, Sharma HN, Abugri DA. Catechin gallate triggers metabolomic and lipidomic alteration in Toxoplasma gondii. Parasit Vectors. 2025;18(1). https://doi.org/10.1186/s13071-025-06869-x
  33. 33. Chetia M, Das R. Effect of (-)-epicatechin, a flavonoid on the NO and NOS activity of Raillietina echinobothrida. Acta Trop. 2018;178:311–7. https://doi.org/10.1016/j.actatropica.2017.12.001
  34. 34. Majumder N, Ganguly S, Ghosh AK, Kundu S, Banerjee A, Saha S. Chlorogenic acid acts upon Leishmania donovani arresting cell cycle and modulating cytokines and nitric oxide in vitro. Parasite Immunol. 2020;42(6):e12719. https://doi.org/10.1111/pim.12719
  35. 35. Mondal C, Mandal S, Saha S, Ray MS, Lyndem LM. Gallic acid and catechin induce morphological alterations on the zoonotic parasite Hymenolepis diminuta. Parasitol Res. 2023;122(10):2287–99. https://doi.org/10.1007/s00436-023-07929-w
  36. 36. Nicoletti M. The antioxidant activity of mistletoes (Viscum album and other species). Plants. 2023;12(14):2707. https://doi.org/10.3390/plants12142707
  37. 37. Omeje EO, Osadebe PO, Esimone CO, Nworu CS, Kawamura A, Proksch P. Three hydroxylated lupeol-based triterpenoid esters isolated from the Eastern Nigeria mistletoe parasitic on Kola acuminata. Nat Prod Res. 2012;26(19):1775–81. https://doi.org/10.1080/14786419.2011.603316
  38. 38. da Silva Dutra M, Araújo PRM, Gleiciane da Rocha M, Pereira VC, Freitas AS, Pereira Lopes RG, et al. Antimicrobial and antiparasitic potential of lupeol: antifungal effect on the Candida parapsilosis species complex and nematicidal activity against Caenorhabditis elegans. J Med Microbiol. 2025;74(3):001976. https://doi.org/10.1099/jmm.0.001976
  39. 39. Siddiqui R, Akbar N, Khatoon B, Kawish M, Ali MS, Shah MR, et al. Novel plant-based metabolites as disinfectants against Acanthamoeba castellanii. Antibiotics. 2022;11(2):248. https://doi.org/10.3390/antibiotics11020248
  40. 40. de C, Albuquerque RS, Brito DI V, Lavor AKLS, Alencar LBB, Tintino S, et al. In vitro cytotoxic and antiparasitic activity of caryophyllene and eugenol against Trypanosoma cruzi and Leishmania brasiliensis. Rev Cuba Plantas Med. 2013;18:522–8.
  41. 41. da Silva TB, Menezes LRA, Sampaio MFC, Meira CS, Guimarães ET, Soares MBP, et al. Chemical composition and anti-Trypanosoma cruzi activity of essential oils obtained from leaves of Xylopia frutescens and X. laevigata (Annonaceae). Nat Prod Commun. 2013;8(3). https://doi.org/10.1177/1934578X1300800332
  42. 42. Majid Shah S, Ullah F, Ayaz M, Sadiq A, Hussain S, Ali Shah A ul H, et al. β-Sitosterol from Ifloga spicata (Forssk.) Sch. Bip. As potential anti-leishmanial agent against Leishmania tropica: docking and molecular insights. Steroids. 2019;148:56–62. https://doi.org/10.1016/j.steroids.2019.05.001
  43. 43. Pramanik PK, Chakraborti S, Bagchi A, Chakraborti T. Bioassay-based Corchorus capsularis L. leaf-derived β-sitosterol exerts antileishmanial effects against Leishmania donovani by targeting trypanothione reductase. Sci Rep. 2020;10(1):20440. https://doi.org/10.1038/s41598-020-77066-2
  44. 44. de Moraes J, de Oliveira RN, Costa JP, Junior ALG, de Sousa DP, Freitas RM, et al. Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease Schistosomiasis mansoni. PLoS Negl Trop Dis. 2014;8(1):e2617. https://doi.org/10.1371/journal.pntd.0002617
  45. 45. López-López LP, Hernández-Cuevas NA, Acosta-Viana KY, Arana-Argáez VE, Torres-Romero JC, Polanco-Hernández GM. Activity of β-caryophyllene oxide and benznidazole mixture against Trypanosoma cruzi and in silico prediction of anti-trypanocidal interaction. Sci Pharm. 2025;93(3):40. https://doi.org/10.3390/scipharm93030040

Downloads

Download data is not yet available.